0	3	Bik	Bik	NNP
3	4	,	,	,
5	6	a	a	DT
7	12	novel	novel	JJ
13	27	death-inducing	death-inducing	JJ
28	35	protein	protein	NN
36	42	shares	share	VBZ
43	44	a	a	DT
45	53	distinct	distinct	JJ
54	62	sequence	sequence	NN
63	68	motif	motif	NN
69	73	with	with	IN
74	79	Bcl-2	bcl-2	NN
80	86	family	family	NN
87	95	proteins	protein	NNS
96	99	and	and	CC
100	109	interacts	interact	VBZ
110	114	with	with	IN
115	120	viral	viral	JJ
121	124	and	and	CC
125	133	cellular	cellular	JJ
134	152	survival-promoting	survival-promoting	JJ
153	161	proteins	protein	NNS
161	162	.	.	.

164	167	The	the	DT
168	186	survival-promoting	survival-promoting	JJ
187	195	activity	activity	NN
196	198	of	of	IN
199	202	the	the	DT
203	208	Bcl-2	bcl-2	NN
209	215	family	family	NN
216	218	of	of	IN
219	227	proteins	protein	NNS
228	235	appears	appear	VBZ
236	238	to	to	TO
239	241	be	be	VB
242	251	modulated	modulate	VBN
252	254	by	by	IN
255	267	interactions	interaction	NNS
268	275	between	between	IN
276	283	various	various	JJ
284	292	cellular	cellular	JJ
293	301	proteins	protein	NNS
301	302	.	.	.

303	305	We	we	PRP
306	310	have	have	VBP
311	321	identified	identify	VBN
322	323	a	a	DT
324	329	novel	novel	JJ
330	338	cellular	cellular	JJ
339	346	protein	protein	NN
346	347	,	,	,
348	351	Bik	Bik	NNP
351	352	,	,	,
353	357	that	that	WDT
358	367	interacts	interact	VBZ
368	372	with	with	IN
373	376	the	the	DT
377	385	cellular	cellular	JJ
386	404	survival-promoting	survival-promoting	JJ
405	413	proteins	protein	NNS
413	414	,	,	,
415	420	Bcl-2	Bcl-2	NNP
421	424	and	and	CC
425	431	Bcl-xL	Bcl-xL	NNP
431	432	,	,	,
433	435	as	as	RB
436	440	well	well	RB
441	443	as	as	IN
444	447	the	the	DT
448	453	viral	viral	JJ
454	472	survival-promoting	survival-promoting	JJ
473	481	proteins	protein	NNS
481	482	,	,	,
483	490	Epstein	Epstein	NNP
491	495	Barr	Barr	NNP
496	507	virus-BHRF1	virus-bhrf1	NN
508	511	and	and	CC
512	522	adenovirus	adenovirus	NN
523	529	E1B-19	e1b-19	NN
530	533	kDa	kda	NN
533	534	.	.	.

535	537	In	in	IN
538	547	transient	transient	JJ
548	560	transfection	transfection	NN
561	567	assays	assay	NNS
567	568	,	,	,
569	572	Bik	Bik	NNP
573	581	promotes	promote	VBZ
582	586	cell	cell	NN
587	592	death	death	NN
593	595	in	in	IN
596	597	a	a	DT
598	604	manner	manner	NN
605	612	similar	similar	JJ
613	615	to	to	TO
616	619	the	the	DT
620	635	death-promoting	death-promoting	JJ
636	643	members	member	NNS
644	646	of	of	IN
647	650	the	the	DT
651	656	Bcl-2	bcl-2	NN
657	663	family	family	NN
663	664	,	,	,
665	668	Bax	Bax	NNP
669	672	and	and	CC
673	676	Bak	Bak	NNP
676	677	.	.	.

678	682	This	this	DT
683	698	death-promoting	death-promoting	JJ
699	707	activity	activity	NN
708	710	of	of	IN
711	714	Bik	Bik	NNP
715	718	can	can	MD
719	721	be	be	VB
722	732	suppressed	suppress	VBN
733	735	by	by	IN
736	748	coexpression	coexpression	NN
749	751	of	of	IN
752	757	Bcl-2	bcl-2	NN
757	758	,	,	,
759	765	Bcl-XL	Bcl-XL	NNP
765	766	,	,	,
767	776	EBV-BHRF1	ebv-bhrf1	NN
777	780	and	and	CC
781	787	E1B-19	e1b-19	NN
788	791	kDa	kda	NN
792	800	proteins	protein	NNS
801	811	suggesting	suggest	VBG
812	816	that	that	IN
817	820	Bik	Bik	NNP
821	824	may	may	MD
825	827	be	be	VB
828	829	a	a	DT
830	836	common	common	JJ
837	843	target	target	NN
844	847	for	for	IN
848	852	both	both	CC
853	861	cellular	cellular	JJ
862	865	and	and	CC
866	871	viral	viral	JJ
872	886	anti-apoptotic	anti-apoptotic	JJ
887	895	proteins	protein	NNS
895	896	.	.	.

897	902	While	while	IN
903	906	Bik	Bik	NNP
907	911	does	do	VBZ
912	915	not	not	RB
916	920	show	show	VB
921	926	overt	overt	JJ
927	935	homology	homology	NN
936	938	to	to	TO
939	942	the	the	DT
943	946	BH1	bh1	NN
947	950	and	and	CC
951	954	BH2	bh2	NN
955	964	conserved	conserve	VBN
965	972	domains	domain	NNS
973	987	characteristic	characteristic	JJ
988	990	of	of	IN
991	994	the	the	DT
995	1000	Bcl-2	bcl-2	NN
1001	1007	family	family	NN
1007	1008	,	,	,
1009	1011	it	it	PRP
1012	1016	does	do	VBZ
1017	1022	share	share	VB
1023	1024	a	a	DT
1025	1026	9	9	CD
1027	1032	amino	amino	NN
1033	1037	acid	acid	NN
1038	1044	domain	domain	NN
1045	1046	(	(	(
1046	1049	BH3	BH3	NNP
1049	1050	)	)	)
1051	1055	with	with	IN
1056	1059	Bax	Bax	NNP
1060	1063	and	and	CC
1064	1067	Bak	Bak	NNP
1068	1073	which	which	WDT
1074	1077	may	may	MD
1078	1080	be	be	VB
1081	1082	a	a	DT
1083	1091	critical	critical	JJ
1092	1103	determinant	determinant	NN
1104	1107	for	for	IN
1108	1111	the	the	DT
1112	1127	death-promoting	death-promoting	JJ
1128	1136	activity	activity	NN
1137	1139	of	of	IN
1140	1145	these	these	DT
1146	1154	proteins	protein	NNS
1154	1155	.	.	.